We accept a variety of insurance plans. Please contact us to confirm your coverage.

How Does Spravato Work? Understanding Its Effects on the Brain

How Does Spravato Work

Spravato works by targeting glutamate, a brain chemical that helps nerve cells communicate, instead of serotonin like most antidepressants. This may help some people feel relief sooner than they would with daily pills. Each dose happens during a scheduled clinic visit, so you never take Spravato at home. After you use the spray, a care team stays with you for at least two hours. Some people feel dizzy, sleepy, or a little disconnected during this time, but these effects usually fade before the visit ends. Since Spravato can affect alertness, plan for someone else to drive you home. Most people start with two sessions a week during the first month, and visits become less frequent as symptoms improve. Our team at Radiant Path Therapy and Psychiatry offers Spravato treatment to patients across the Inland Empire at our Grand Terrace, Redlands, and Corona clinics, and we’ll guide you through each stage so you always know what comes next. What Is Spravato and What Is It Used For? Spravato is the brand name for esketamine, a prescription medicine given as a nasal spray. The U.S. Food and Drug Administration (FDA) approved it for adults with treatment-resistant depression. It is also approved for depressive symptoms in adults with major depressive disorder who have acute suicidal thoughts or behavior, when used with an oral antidepressant. Treatment-resistant depression means that a person has not had enough improvement after trying other antidepressant treatments.  The exact treatment history and diagnosis must be reviewed by a qualified healthcare provider.  In January 2025, the FDA expanded Spravato’s approval to allow it to be used alone for adults with treatment-resistant depression. It may also be prescribed with an oral antidepressant, depending on the patient’s treatment plan.  The Ohio Northern University review of Spravato’s approval discusses this change and explains why esketamine is different from many older antidepressants. Spravato is not approved for children. It is also not a general treatment for every type of depression. A provider must decide whether it is appropriate based on a person’s symptoms, medical history, previous treatments, and possible risks. How Does Spravato Work in the Brain? Spravato works by blocking NMDA receptors, which are involved in how brain cells respond to glutamate. This may increase activity through other receptors, including AMPA receptors, and support changes in brain cell connections that help regulate mood. A 2026 review by van Hoogdalem and colleagues in Clinical and Translational Science explains how esketamine affects NMDA receptors, increases glutamate signaling through AMPA receptors, and may support new connections between brain cells. However, the exact way Spravato improves depression is still being studied. What Is the Role of Glutamate? Glutamate is a brain chemical that helps nerve cells communicate. It plays an important role in learning, memory, and mood regulation. Researchers believe changes in glutamate signaling may be involved in depression. Unlike traditional antidepressants that mainly affect serotonin or norepinephrine, Spravato works through the glutamate system. How Does Esketamine Affect NMDA Receptors? Esketamine blocks NMDA receptors, which normally respond to glutamate. This can temporarily change how nerve cells communicate and increase glutamate signaling through other receptors. Researchers believe these changes may help explain Spravato’s antidepressant effects, although the exact process is not fully understood. What Are AMPA Receptors and Brain Cell Connections? AMPA receptors help brain cells communicate using glutamate. When esketamine blocks certain NMDA receptors, it may increase activity through AMPA receptors and support synaptic plasticity. Synaptic plasticity is the brain’s ability to strengthen or change connections between nerve cells. Researchers believe this process may contribute to improvements in depression symptoms, but results vary between patients. How Is Spravato Different From Traditional Antidepressants? Spravato differs from traditional antidepressants in how it affects the brain, how it is administered, and how quickly it may work. While many antidepressants target serotonin or norepinephrine, Spravato affects glutamate signaling through NMDA receptors. Some patients may notice improvement sooner, although results vary. Feature Spravato Traditional Antidepressants How it works Affects glutamate signaling through NMDA receptors Often target serotonin, norepinephrine, or both How it is taken Nasal spray under medical supervision Usually oral tablets or capsules Treatment location Certified healthcare setting Usually taken at home Monitoring At least 2 hours after each dose Routine medical follow-ups Treatment frequency Initially twice weekly, then less often Usually taken daily Response time Some patients improve within 24 hours Often take several weeks to show full effects Spravato is generally considered for certain adults with treatment-resistant depression, while traditional antidepressants are used for a wider range of patients. A healthcare provider can determine which treatment is appropriate based on symptoms, medical history, and previous treatment results. Spravato vs. IV Ketamine: What Is the Difference? Spravato and IV ketamine are related treatments, but they are not the same. Spravato contains esketamine, which is one form of ketamine. It is an FDA-approved nasal spray for specific depression-related uses. IV ketamine is given through a vein and is not FDA-approved for depression, although some providers use it off-label. Feature Spravato IV ketamine Medication Esketamine Ketamine Form Nasal spray Intravenous infusion FDA approval for depression Approved for specific adult indications Not FDA-approved for depression Administration Under supervision in a certified healthcare setting Given by a healthcare professional Monitoring At least two hours after each dose Monitoring depends on the clinical setting and protocol Treatment plan Follows the approved dosing schedule and individual response Schedule varies by provider and treatment plan Both treatments can cause changes in perception, dizziness, sedation, and increases in blood pressure. Their approval status, dosing, and monitoring requirements are different. A healthcare provider can explain which options are appropriate and what evidence supports each one. How Quickly Does Spravato Start Working? Some people experience improvement in depressive symptoms within the first day after treatment, but this does not happen for everyone. In clinical studies, changes in depression scores were observed as early as 24 hours after a dose. The timing and amount of improvement can vary. Some people need several sessions before they and their provider can judge whether

Schedule a Consultation